Related Information

Media Inquires: 
Cecilia Arradaza
Communications Director
(202) 336-8912 (office)
Carradaza@fastercures.org 

Stay connected. Sign up now to be informed of the latest FasterCures blogs, events and program updates.

 

Press Releases

FasterCures Supports Grassroots Approach to Medical Research
Washington, DC - Jul 07, 2009

FasterCures announced its support of Research Revolution, 23andMe's just launched effort that aims to change the way we learn about how genes and environment affect the causes and treatments of disease.

"In fighting disease, patience is not a virtue.  Patients are.  FasterCures supports efforts like 23andMe's Reserach Revolution that engage patients, the most valuable research in medical research," said Margaret Anderson, COO, FasterCures. 

23andMe hopes to do research on dozens of diseases, starting with these 10:

  • ALS
  • Celiac Disease
  • Epilepsy
  • Lymphoma and Leukemia
  • Migraines
  • Multiple Sclerosis
  • Psoriasis
  • Rheumatoid Arthritis
  • Severe Food Allergies
  • Testicular Cancer

Learn more about the Research Revolution

About FasterCures
FasterCures/The Center for Accelerating Medical Solutions is committed to saving lives by saving time in the research, discovery and development of new treatments for deadly and debilitating diseases. FasterCures, a center of the Milken Institute, is nonpartisan, nonprofit and independent of interest groups. For more information, visit http://www.fastercures.org
 
About 23andMe
23andMe, Inc. is a privately-held company dedicated to helping individuals understand their own genetic information using recent advances in DNA analysis technologies and web-based interactive tools. 23andMe enables individuals to gain deeper insights into personal ancestry, genealogy and inherited traits. 23andMe was founded in April 2006 by Linda Avey and Anne Wojcicki. More information is available at http://www.23andme.com.

 

< back